Certified by Founder Lodge
SV Health Investors
United Kingdom - London, London
INVESTOR
1 Disclosed Funding Rounds $125,000,000
11 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, heal
| Company | Date | Round | Raised |
|---|---|---|---|
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 Therini Bio, Inc. |
April, 27 ,2023 | Series A | $36,000,000 |
 Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 Harness Therapeutics |
December, 01 ,2023 | Unknown | $5,067,000 |
 Miach Orthopaedics, Inc. |
April, 04 ,2024 | Series B | $20,000,000 |
 Brixton Biosciences |
May, 15 ,2024 | Series B | $33,000,000 |
 Spineology Inc. |
August, 07 ,2024 | Unknown | $25,000,000 |
 SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
 LoQus23 Therapeutics Ltd |
October, 02 ,2024 | Series A | $46,550,175 |
 Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Decart | $21,000,000 | (Nov 1, 2024)
Keel | $5,933,454 | (Nov 1, 2024)
Cold | $2,650,000 | (Nov 1, 2024)
MealMe, Inc. | $8,000,000 | (Nov 1, 2024)
autarkize | $2,502,492 | (Nov 1, 2024)
